2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd
(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Source: stockhouse.com
Mori Arkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mori Arkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mori Arkin Today - Breaking & Trending Today
Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream -April 01, 2024 at 07:00 am EDT
NESS ZIONA, Israel, April 01, 2024 -- Sol-Gel Technologies, Ltd. , a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of...
Source: marketscreener.com
Padagis Israel Pharmaceuticals Submits First-to-File ANDA for Generic Version of Roflumilast
The application for generic roflumilast cream, 0.3%, for plaque psoriasis may end up entitling Padagis to 180 days of market exclusivity.
Source: hcplive.com
Odysight.ai Inc. Announces Website Posting of Letter to Shareholders
OMER, Israel, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: SCTC), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, today announced that it had posted a letter to shareholders on the Company’s investor relations website at https://www.odysight.ai/ following the recent filing of the Company's Form 10-Q for the quarterly period ended June 30, 2023. The letter to shareholders is reproduced below. Dear esteemed shareholder,
Source: yahoo.com
10 Best Revenue Growth Stocks to Buy
In this piece, we will take a look at the ten best revenue growth stocks to buy. If you want to skip over the latest news for the stock market and want to jump ahead to the top five stocks in this list, then take a look at 5 Best Revenue Growth Stocks to Buy. […]
Source: yahoo.com